LifeMD Inc
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature e… Read more
LifeMD Inc (LFMD) - Net Assets
Latest net assets as of December 2025: $23.16 Million USD
Based on the latest financial reports, LifeMD Inc (LFMD) has net assets worth $23.16 Million USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($70.41 Million) and total liabilities ($47.25 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $23.16 Million |
| % of Total Assets | 32.89% |
| Annual Growth Rate | N/A |
| 5-Year Change | -10.31% |
| 10-Year Change | N/A |
| Growth Volatility | 119.88 |
LifeMD Inc - Net Assets Trend (2011–2025)
This chart illustrates how LifeMD Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for LifeMD Inc (2011–2025)
The table below shows the annual net assets of LifeMD Inc from 2011 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $23.16 Million | +672.42% |
| 2024-12-31 | $-4.05 Million | -172.68% |
| 2023-12-31 | $5.57 Million | +176.19% |
| 2022-12-31 | $-7.31 Million | -128.29% |
| 2021-12-31 | $25.82 Million | +3241.91% |
| 2020-12-31 | $-821.76K | +27.23% |
| 2019-12-31 | $-1.13 Million | -237.76% |
| 2018-12-31 | $819.74K | +31.61% |
| 2017-12-31 | $622.84K | +272.19% |
| 2016-12-31 | $-361.73K | -299.86% |
| 2015-12-31 | $180.99K | +229.74% |
| 2014-12-31 | $-139.50K | -171.36% |
| 2013-12-31 | $195.49K | +44.81% |
| 2012-12-31 | $135.00K | +147.71% |
| 2011-12-31 | $-282.98K | -- |
Equity Component Analysis
This analysis shows how different components contribute to LifeMD Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 22125312500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $467.60K | 2.02% |
| Other Components | $251.29 Million | 1085.19% |
| Total Equity | $23.16 Million | 100.00% |
LifeMD Inc Competitors by Market Cap
The table below lists competitors of LifeMD Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ningbo Yibin Electronic Technology Co. Ltd. Cl A
SHE:001278
|
$175.18 Million |
|
Berkeley Energy Ltd
PINK:BKLRF
|
$175.19 Million |
|
Ningbo David Medical Device Co Ltd
SHE:300314
|
$175.22 Million |
|
Zinwell Corporation
TW:2485
|
$175.23 Million |
|
Jinglv Envi Science & Tech Co
SHE:001230
|
$175.09 Million |
|
Bank Net Indonesia Syariah Tbk PT
JK:BANK
|
$175.00 Million |
|
Gulf Oil Lubricants India Limited
NSE:GULFOILLUB
|
$174.99 Million |
|
Central Hydropower JSC
VN:CHP
|
$174.98 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in LifeMD Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -5,485,501 to 23,156,580, a change of 28,642,081.
- Net income of 11,247,856 contributed positively to equity growth.
- Dividend payments of 3,106,250 reduced retained earnings.
- Other factors increased equity by 20,500,475.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $11.25 Million | +48.57% |
| Dividends Paid | $3.11 Million | -13.41% |
| Other Changes | $20.50 Million | +88.53% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares LifeMD Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 8.65x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-12-31 | $-0.04 | $4.44 | x |
| 2012-12-31 | $0.02 | $4.44 | x |
| 2013-12-31 | $0.03 | $4.44 | x |
| 2014-12-31 | $-0.02 | $4.44 | x |
| 2015-12-31 | $0.02 | $4.44 | x |
| 2016-12-31 | $-0.05 | $4.44 | x |
| 2017-12-31 | $0.10 | $4.44 | x |
| 2018-12-31 | $0.10 | $4.44 | x |
| 2019-12-31 | $-0.10 | $4.44 | x |
| 2020-12-31 | $0.09 | $4.44 | x |
| 2021-12-31 | $0.99 | $4.44 | x |
| 2022-12-31 | $-0.22 | $4.44 | x |
| 2023-12-31 | $0.10 | $4.44 | x |
| 2024-12-31 | $-0.13 | $4.44 | x |
| 2025-12-31 | $0.51 | $4.44 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently LifeMD Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 48.57%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.80%
- • Asset Turnover: 2.76x
- • Equity Multiplier: 3.04x
- Recent ROE (48.57%) is above the historical average (-402.69%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 0.00% | -67.61% | 2.17x | 0.00x | $-474.63K |
| 2012 | -330.11% | -66.14% | 1.82x | 2.74x | $-459.15K |
| 2013 | -137.23% | -33.19% | 1.47x | 2.82x | $-287.81K |
| 2014 | 0.00% | -64.48% | 4.08x | 0.00x | $-446.54K |
| 2015 | -61.94% | -5.09% | 2.72x | 4.48x | $-72.00K |
| 2016 | 0.00% | -21.14% | 6.63x | 0.00x | $-1.07 Million |
| 2017 | -136.74% | -23.86% | 4.00x | 1.43x | $-1.29 Million |
| 2018 | -138.22% | -14.91% | 3.18x | 2.91x | $-1.33 Million |
| 2019 | 0.00% | -25.16% | 3.62x | 0.00x | $-3.04 Million |
| 2020 | -4470.29% | -162.29% | 2.78x | 9.90x | $-60.66 Million |
| 2021 | -226.80% | -65.57% | 1.86x | 1.86x | $-63.58 Million |
| 2022 | 0.00% | -38.25% | 4.64x | 0.00x | $-44.85 Million |
| 2023 | -587.56% | -13.50% | 2.61x | 16.68x | $-20.95 Million |
| 2024 | 0.00% | -8.89% | 2.93x | 0.00x | $-18.33 Million |
| 2025 | 48.57% | 5.80% | 2.76x | 3.04x | $8.93 Million |
Industry Comparison
This section compares LifeMD Inc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $79,108,599
- Average return on equity (ROE) among peers: -247.59%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| LifeMD Inc (LFMD) | $23.16 Million | 0.00% | 2.04x | $175.14 Million |
| Accolade, Inc. (ACCD) | $473.79 Million | -97.02% | 0.91x | $448.32 Million |
| Achiko AG (ACHKF) | $-4.58 Million | 0.00% | 0.00x | $314.42K |
| Ascom Holding AG (ACMLF) | $78.70 Million | 22.11% | 1.51x | $152.13 Million |
| Accelera Innovations Inc (ACNV) | $-462.52K | 0.00% | 0.00x | $5.72K |
| Aclarion Inc (ACON) | $-7.08 Million | 0.00% | 0.00x | $1.89 Million |
| Alternate Health Corp (AHGIF) | $1.07 Million | -2231.82% | 7.94x | $6.50K |
| AI/ML Innovations Inc (AIMLF) | $2.09 Million | -130.52% | 0.72x | $6.84 Million |
| NetraMark Holdings Inc. (AINMF) | $-198.56K | 0.00% | 0.00x | $70.13 Million |
| AMJ Global Technology (AMJT) | $-21.78K | 0.00% | 0.00x | $10.99 Million |
| American Well Corp (AMWL) | $247.79 Million | -38.62% | 0.31x | $78.62 Million |